Back to URGN
TRUIST FINANCIAL CORP URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
6
Latest value
$691
Q3 2026
Peak value
$2.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.4M |
| Q4 2025 | $1.7M |
| Q1 2026 | $1.3M |
| Q2 2026 | $2.7M |
| Q3 2026 | $2.9M |
| Q3 2026 | $691 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $691 | 17 | — | — |
| Q3 2026 | $2.9M | 72.3K | — | — |
| Q2 2026 | $2.7M | 72.3K | — | — |
| Q1 2026 | $1.3M | 72.3K | — | — |
| Q4 2025 | $1.7M | 72.3K | — | — |
| Q3 2025 | $1.4M | 72.3K | — | — |
Other funds holding URGN
$93.6M
$57M
$57M
$48M
$48M
$45M